Herd Health News

March 2011
Indiana Prairie Farmer;Mar2011, Vol. 185 Issue 3, pBP9
The article offers news briefs related to herd health which include the development of treatments against the cattle fever thick that causes Texas fever, the availability of E.coli Bacterial Extract vaccine with SRP technology, and the expansion of Express FP 5-VL5 vaccine' label against Leptospira hardijo-bovis.


Related Articles

  • E. coli vaccine.  // BEEF;Apr2011, Vol. 47 Issue 8, p88 

    The article reports on the availability of E. coli Bacterial vaccine with SRP® technology from Pfizer Animal Health.

  • Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation. Daley, Alexandra; Randall, Roger; Darsley, Michael; Choudhry, Naheed; Thomas, Nicola; Sanderson, Ian R.; Croft, Nick M.; Kelly, Paul // Gut;Nov2007, Vol. 56 Issue 11, p1550 

    Objective: Enterotoxigenic Escherichia coli (ETEC) is a major cause of acute diarrhoea in children in the developing world, in travellers and in the military. Safe, effective vaccines could reduce morbidity and mortality. As immunity to ETEC is strain specific, the ability to create vaccines in...

  • Jabs fight death after dinner. Coghlan, Andy // New Scientist;02/21/98, Vol. 157 Issue 2122, p20 

    Reports on a prototype vaccine which was developed by the National Institute of Child Health and Human Development in Bethesda, Maryland, which protects against Escherichia coli 0157, a food-borne disease. Details on the vaccine; Comments from Duane Alexander, director of the institute.

  • Partnership Creating Vaccine for 'Hamburger Disease'  // R&D Magazine;Sep2000, Vol. 42 Issue 9, pI-32 

    Focuses on the partnership agreement signed by the National Research Council's Institute for Biological Sciences with Foragen Technology Ventures Inc. to test a vaccine against hamburger disease. Primary source of E.coli 0157 bacterium for humans; Function of the vaccine; Details on the...

  • FimH adhesin molecule targeted in new UTI vaccines. Taggart, Martha // Urology Times;Jul2001, Vol. 29 Issue 7, p17 

    Reports on vaccines being developed against uropathogenic Escherichia coli, the causative agent of majority of urinary tract infections as of July 2001. MedImmune's development of a vaccine against the FimH adhesin molecule which mediates Escherichia coli's binding to the bladder mucosa.

  • Antibody-mediated disruption of the mechanics of CS20 fimbriae of enterotoxigenic Escherichia coli. Singh, Bhupender; Mortezaei, Narges; Uhlin, Bernt Eric; Savarino, Stephen J.; Bullitt, Esther; Andersson, Magnus // Scientific Reports;10/2/2015, p13678 

    Preventive vaccines against enterotoxigenic Escherichia coli (ETEC) are being developed, many of which target common fimbrial colonization factors as the major constituent, based on empirical evidence that these function as protective antigens. Particularly, passive oral administration of ETEC...

  • Vaccine makes inroads into E coli infections.  // Poultry World;Jul2013, Vol. 166 Issue 7, p32 

    The article highlights the increasing benefits of vaccination on the prevalence of E coli in Great Britain. James Porritt, Zoetis poultry manager for Great Britain and Ireland, revealed that with the encouraging feedback from producers and veterinary surgeons, their next step will be to conduct...

  • Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine. Skibinski, David A. G.; Hanson, Brendon J.; Lin, Yufang; von Messling, Veronika; Jegerlehner, Andrea; Tee, Jason Boon Sern; Chye, De Hoe; Wong, Steven K. K.; Ng, Amanda A. P.; Lee, Hui Yin; Au, Bijin; Lee, Bernett T. K.; Santoso, Lucia; Poidinger, Michael; Fairhurst, Anna-Marie; Matter, Alex; Bachmann, Martin F.; Saudan, Philippe; Connolly, John E. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Influenza pandemics can spread quickly and cost millions of lives; the 2009 H1N1 pandemic highlighted the shortfall in the current vaccine strategy and the need for an improved global response in terms of shortening the time required to manufacture the vaccine and increasing production capacity....

  • pretoria, south africaOur packaging has buttered up some media attention. Schutte, Danie // Farmers Weekly;10/17/2014, Vol. 161 Issue 40, p1 

    A personal narrative is presented which explores the author's experience on discovering redwater disorder in his newly bought animals and isolating rest of the animals to safeguard them from the infection.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics